|
End-of-day quote
Korea S.E.
14/09/2026
|
5-day change | 1st Jan Change | ||
| 16,270.00 KRW | -3.56% |
|
-10.90% | -71.66% |
| 23/07 | Samsung EpiS Unit Signs Cancer Drug Development, Commercialization Deal with IntoCell | MT |
| 22/12 | IntoCell, Inc.(KOSDAQ:A287840) added to S&P Global BMI Index | CI |
Chart: Technical Analysis
Korea S.E.KRW
| Markets | Quality | ||
|---|---|---|---|
Korea S.E.
| A287840 | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 19,380 | 23,400 | 37,300 |
| Spread/Res. | -16.05% | -30.47% | -56.38% |
| Spread/Supp. | +3.59% | +17.47% | +0.56% |
| Support | 15,706.8 | 13,850 | 16,180 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- A287840 Stock
- Charts IntoCell, Inc.
Select your edition
All financial news and data tailored to specific country editions
